Works matching IS 10031057 AND DT 2021 AND VI 30 AND IP 8

Results: 11

The research group of Professor Ming Ma has prepared novel natural Lasso Peptides based on biosynthetic and chemical modifications.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 703, doi. 10.1039/D1SC02695J
Publication type:: Article

The research group of Professor Qi Sun has made new progress on α7 nAChR positive allosteric modulator and its improvement in cognitive dysfunction.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 701, doi. 10.1021/acs.jmedchem.1c01058
Publication type:: Article

The research group of Professor Qing Xia has developed gene codon extension technology to treat nonsense mutation rare diseases.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 699
Publication type:: Article

Effects of linagliptin on inflammatory factors and arteriosclerosis in patients with newly diagnosed type 2 diabetes mellitus.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 692, doi. 10.5246/jcps.2021.08.057

By:

Rui Li;
Yanru Kong

Publication type:

Article

Analysis of anti-infection therapeutic schedule analysis for neonatal Streptococcus agalactiae meningitis and discussion on the indications for drug withdrawal.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 686, doi. 10.5246/jcps.2021.08.056

By:

Haiyan Wu;
Tao Wang;
Qian Wang;
Lin Tang

Publication type:

Article

Anti-inflammatory effects of diaporisoindole B in LPS-stimulated RAW 264.7 macrophage cells via MyD88 activated NF-κB and MAPKs pathways.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 675, doi. 10.5246/jcps.2021.08.055

By:

Hongju Liu;
Jing Li;
Huiyi Xie;
Lingling Wang;
Zhizhen Zhang;
Chong Yan

Publication type:

Article

The reversal effect of capsaicin on doxorubicin-resistant breast cancer cells.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 666, doi. 10.5246/jcps.2021.08.054

By:

Yi Zhou;
Ting Wang;
Jiajia Zhao;
Xuehua Jiang

Publication type:

Article

Acute oral toxicity test and assessment of rhynchophylline in mice.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 657, doi. 10.5246/jcps.2021.08.053

By:

Lanlan Hu;
Huijing Zhang;
Le Zhang;
Jianlin Tang

Publication type:

Article

In vitro metabolism and inhibitory effects of atractylenolide II on various hepatic CYPs in HLMs.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 645, doi. 10.5246/jcps.2021.08.052

By:

Xulong Chen;
Zhenggen Liao;
Cheng Li;
Guoyong Huang;
Yunyan Song;
Wei Dong;
Abid Naeem;
Xinli Liang

Publication type:

Article

Synthesis, cytotoxicity assay, and molecular docking study of hydroxychalcone derivatives as potential tyrosinase inhibitors.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 634, doi. 10.5246/jcps.2021.08.051

By:

Stiawan, Aris;
Sholikhah, Eti Nurwening;
Kurniawan, Yehezkiel Steven;
Priastomo, Yoga;
Jumina

Publication type:

Article

An overview of Pu-erh tea and its health-promoting effects of lipid-lowering and anti-obesity.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 623, doi. 10.5246/jcps.2021.08.050

By:

Wei Chiang Chan, Eric;
Siu Kuin Wong;
Hung Tuck Chan

Publication type:

Article